Could a malaria drug treat cervical Pre-Cancer?
Disease control
Recruiting now
This phase II trial tests whether artesunate, a drug originally used for malaria, can reverse cervical pre-cancer (CIN2/3) when given as a vaginal insert. About 78 women with high-grade cervical lesions will receive either artesunate or a placebo for three 5-day cycles. The main …
Phase: PHASE2 • Sponsor: Frantz Viral Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC